70 related articles for article (PubMed ID: 9570172)
1. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Carratalà J; Rosón B; Fernández-Sevilla A; Alcaide F; Gudiol F
Arch Intern Med; 1998 Apr; 158(8):868-72. PubMed ID: 9570172
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Gram-Negative Bacteremia and Mortality in Neutropenic Patients with Hematologic Malignancies in a High-Resistance Setting.
Ayaz CM; Hazırolan G; Sancak B; Hascelik G; Akova M
Infect Dis Clin Microbiol; 2022 Jun; 4(2):87-98. PubMed ID: 38633337
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer.
Lee M; Lee CM; Byun JM; Shin DY; Koh Y; Hong J; Choe PG; Park WB; Kim NJ; Yoon SS; Oh MD; Kang CK; Kim I
J Infect Chemother; 2024 Mar; ():. PubMed ID: 38518846
[TBL] [Abstract][Full Text] [Related]
4. The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients.
Castelli V; Sastre-Escolà E; Puerta-Alcalde P; Huete-Álava L; Laporte-Amargós J; Bergas A; Chumbita M; Marín M; Domingo-Domenech E; Badia-Tejero AM; Pons-Oltra P; García-Vidal C; Carratalà J; Gudiol C
Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136755
[TBL] [Abstract][Full Text] [Related]
5. Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice.
Ogunniyi AD; Nguyen HT; Hansford KA; Cooper MA; Trott DJ; Blaskovich MAT
Microbiol Spectr; 2023 Aug; 11(5):e0445922. PubMed ID: 37606382
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for 30-Day Mortality in Patients with Bacteremic Pneumonia Caused by
Zhao C; Zheng Y; Hang Y; Chen Y; Liu Y; Zhu J; Fang Y; Xiong J; Hu L
Int J Gen Med; 2023; 16():6163-6176. PubMed ID: 38164517
[TBL] [Abstract][Full Text] [Related]
7. Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.
Wong JL; Evans SE
Clin Chest Med; 2017 Jun; 38(2):263-277. PubMed ID: 28477638
[TBL] [Abstract][Full Text] [Related]
8. Outcomes from bacteremic donors in lung transplantation.
Shah SZ; Pouch SM; Keller BC; Pope-Harman A; Tumin D
J Heart Lung Transplant; 2017 Jul; ():. PubMed ID: 28823392
[No Abstract] [Full Text] [Related]
9. Severe Pseudomonas aeruginosa Pneumonia in a Breast Cancer Patient Despite Pegfilgrastim Administration.
Fukuma Y; Nomura T; Mikami T; Tanaka K; Taira N
Cureus; 2024 Mar; 16(3):e57156. PubMed ID: 38686264
[TBL] [Abstract][Full Text] [Related]
10. Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against
Askarian F; Tsai CM; Cordara G; Zurich RH; Bjånes E; Golten O; Vinther Sørensen H; Kousha A; Meier A; Chikwati E; Bruun JA; Ludviksen JA; Choudhury B; Trieu D; Davis S; Edvardsen PKT; Mollnes TE; Liu GY; Krengel U; Conrad DJ; Vaaje-Kolstad G; Nizet V
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2301538120. PubMed ID: 37459522
[No Abstract] [Full Text] [Related]
11. Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period.
Gaffney KJ; Urban TA; Lucena M; Rybicki L; Majhail NS; Mossad SB
Clin Hematol Int; 2023 Jun; 5(2-3):65-70. PubMed ID: 36738438
[TBL] [Abstract][Full Text] [Related]
12. Mitigating acute chemotherapy-associated adverse events in patients with cancer.
Kuderer NM; Desai A; Lustberg MB; Lyman GH
Nat Rev Clin Oncol; 2022 Nov; 19(11):681-697. PubMed ID: 36221000
[TBL] [Abstract][Full Text] [Related]
13. Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis.
Hung YP; Lee CC; Ko WC
Front Med (Lausanne); 2022; 9():869822. PubMed ID: 35712120
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele.
Tu J; MacDonald M; Mansfield D
Respirol Case Rep; 2022 Jun; 10(6):e0954. PubMed ID: 35509978
[TBL] [Abstract][Full Text] [Related]
15. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with
Albasanz-Puig A; Durà-Miralles X; Laporte-Amargós J; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo JM; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Morales HMP; Brunel AS; García E; Isler B; Kern WV; Retamar-Gentil P; Aguado JM; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmati P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Pallarès N; Bergas A; Carratalà J; Gudiol C; On Behalf Of The Ironic Study Group
Microorganisms; 2022 Mar; 10(4):. PubMed ID: 35456784
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients.
Fontana NS; Ibrahim KY; Bonazzi PR; Rossi F; Almeida SCG; Tengan FM; Brandileone MCC; Abdala E
Sci Rep; 2021 Feb; 11(1):3699. PubMed ID: 33580101
[TBL] [Abstract][Full Text] [Related]
17. Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
Guarana M; Nucci M; Nouér SA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405857
[TBL] [Abstract][Full Text] [Related]
18. Immunological considerations in the development of
Baker SM; McLachlan JB; Morici LA
Hum Vaccin Immunother; 2020; 16(2):412-418. PubMed ID: 31368828
[No Abstract] [Full Text] [Related]
19. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.
Malhotra S; Hayes D; Wozniak DJ
Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142499
[TBL] [Abstract][Full Text] [Related]
20. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
Schaefers MM; Duan B; Mizrahi B; Lu R; Reznor G; Kohane DS; Priebe GP
Vaccine; 2018 Nov; 36(46):6926-6932. PubMed ID: 30314911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
